| |
BASF PharmaChemikalien GmbH & Co. KG Minden, Germany
The BASF site at Minden has been producing pharmaceutical substances since 1939. Here, BASF operates the largest production facilities in the world for ephedrine, pseudoephedrine, caffeine and theophylline. Moreover, approximately 30 chemically different active ingredients and highly refined intermediates are manufactured in multi-product installations, both for the generic pharmaceuticals market as well as those that are tailor-made to specific customer requirements (custom synthesis).
 |
| Products |
| Active ingredients, advanced intermediates for the pharmaceutical industry |
| |
| Assets |
| 3 production plants, infrastructure facilities |
| |
| Technology |
| Organic chemistry, including chloromethylation, cyanization, chlorinations, hydrogenations |
| |
| Service |
| Commercial production for generic APIs and in the field of custom synthesis |
| |
|
|
|
 |
News |
| |
|
April 30, 2008: BASF sells its Shreveport site and related contract manufacturing business to Dr. Reddy's Laboratories (english, deutsch) January 18, 2008: BASF appoints Folker Ruchatz as head of its custom synthesis business (english, deutsch)
|
|
 |
Product Search |
 |
 |
|